Notes
2015 Canadian dollars
Reference
Fu LW, et al. Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis. Annals of Allergy, Asthma and Immunology 120: 195-199, No. 2, Feb 2018. Available from: URL: http://doi.org/10.1016/j.anai.2017.11.002
Rights and permissions
About this article
Cite this article
Home-based SC immunoglobulin saves costs versus IVIg. PharmacoEcon Outcomes News 797, 18 (2018). https://doi.org/10.1007/s40274-018-4727-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4727-3